🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Dogwood Therapeutics, Inc. (DWTX)
NASDAQ: DWTX · Real-Time Price · USD
1.080
0.00 (0.00%)
At close: Nov 18, 2026, 4:00 PM EST
1.170
+0.090 (8.30%)
Pre-market: Nov 19, 2026, 6:02 AM EST

Dogwood Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Selling, General & Admin
7.016.18.73.724.254.85
Research & Development
11.6121.873.531.738.0710.8
Operating Expenses
18.6227.9712.235.4512.3215.64
Operating Income
-18.61-27.97-12.23-5.45-12.32-15.64
Interest Expense
---0.09---
Interest & Investment Income
0.240.1-0.150.070.01
Currency Exchange Gain (Loss)
-0.06-0.03-0.03---
EBT Excluding Unusual Items
-18.43-27.9-12.35-5.3-12.25-15.64
Gain (Loss) on Sale of Assets
-0-0----
Legal Settlements
------0.33
Other Unusual Items
--6.13----
Pretax Income
-27.63-34.04-12.35-5.3-12.25-15.96
Income Tax Expense
-2.450.22-0---
Net Income
-25.18-34.26-12.35-5.3-12.25-15.96
Preferred Dividends & Other Adjustments
-1.260.51---
Net Income to Common
-25.18-35.51-12.86-5.3-12.25-15.96
Net Income Growth
------
Shares Outstanding (Basic)
2951100
Shares Outstanding (Diluted)
2951100
Shares Change
1665.19%384.29%36.84%69.62%32.91%69.06%
EPS (Basic)
-0.87-7.13-12.52-7.05-27.66-47.90
EPS (Diluted)
-0.87-7.13-12.52-7.05-27.66-48.00
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EBITDA
-18.61-27.97-12.22---
D&A For EBITDA
000.01---
EBIT
-18.61-27.97-12.23-5.45-12.32-15.64
SEC Filings: 10-K · 10-Q